Vermillion, formerly called Ciphergen, said that Debra Young resigned as its vice president and CFO on Nov. 1 for “personal reasons.” Young also entered into a separation agreement and release with Vermillion, releasing any claims she may have against the company. As part of the agreement, she will receive $112,750 in base salary and health and dental benefits under COBRA legislation.
Young was appointed VP and CFO of Vermillion last November after serving as CFO of ViOptix since 2004. Qun (Taya) Zhou, Vermillion’s corporate controller will assume the CFO position on an interim basis. Zhou was controller at ViOptix before joining Vermillion in February.
Julie Stenken was appointed the inaugural Twenty-First Century Chair in Proteomics at the University of Arkansas this week. Stenken was formerly at the Rensselaer Polytechnic Institute and was a J. William Fulbright Fellow at the Karolinska Institute in Sweden.
David Agus was named a board member of Navigenics and the chair of its clinical advisory board at the official launch of the company this week. Agus is the director of the Spielberg Family Center for Applied Proteomics at Cedars-Sinai Medical Center and a co-founder of Navigenics, a personalized medicine firm.
BioTrove named Jeffrey Leathe its CFO this week. He will overee all financial operations and IT infrastructure at the company. He had been executive vice president, CFO, and treasurer for Apogent Technologies.